查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1980779

全球口蹄疫疫苗市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Food and Mouth Disease Vaccine Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 138 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計口蹄疫疫苗市場將從 2025 年的 31.7 億美元成長到 2034 年的 65.8 億美元，2026 年至 2034 年的複合年成長率為 8.46%。

隨著各國政府和獸醫機構加強控制牲畜疾病，全球口蹄疫疫苗市場持續成長。口蹄疫是一種高度傳染性的感染疾病，會影響牛、豬、羊等牲畜，對農業部門造成重大經濟損失。接種疫苗仍然是預防疫情爆發和保護動物健康最有效的策略之一。

對動物保健和牲畜疾病預防計畫的投入增加是推動市場發展的主要因素。許多國家的政府正在進行大規模疫苗宣傳活動，旨在保護牲畜並維持農業生產力。此外，獸用疫苗技術的進步提高了口蹄疫疫苗的有效性和安全性。

隨著全球動物用藥品的需求持續成長，全球口蹄疫疫苗市場預計將擴大。研究機構和製藥公司正致力於研發能夠提供更持久免疫力和更廣泛保護作用的先進疫苗。隨著人們對畜牧業健康管理和食品安全的日益關注，口蹄疫疫苗市場預計將保持穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球口蹄疫疫苗市場：依動物種類分類

  • 市場分析、洞察與預測
  • 牛
  • 綿羊和山羊
  • 豬
  • 其他

第5章：全球口蹄疫疫苗市場：依疫苗類型分類

  • 市場分析、洞察與預測
  • 減毒活病毒疫苗
  • 失活（失活）
  • 其他疫苗

第6章：全球口蹄疫疫苗市場：依通路分類

  • 市場分析、洞察與預測
  • 獸醫醫院和診所
  • 政府機構
  • 其他

第7章 全球口蹄疫疫苗市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Merck & Co. Inc
    • Biogenesis Bago
    • Zoetis Inc
    • Boehringer Ingelheim International GmbH
    • Indian Immunologicals Limited
    • Bayer AG
    • Hester Biosciences Limited
    • Inner Mongolia Biwei Antai Biotechnology Co. Ltd
    • Brilliant Bio Pharma Limited
    • Biovet Private Ltd
簡介目錄
Product Code: VMR112115383

The Food and Mouth Disease Vaccine Market size is expected to reach USD 6.58 Billion in 2034 from USD 3.17 Billion (2025) growing at a CAGR of 8.46% during 2026-2034.

The Global Food and Mouth Disease Vaccine Market is growing as governments and veterinary organizations intensify efforts to control livestock diseases. Foot-and-mouth disease is a highly contagious viral infection that affects cattle, pigs, sheep, and other livestock, causing significant economic losses in the agriculture sector. Vaccination remains one of the most effective strategies for preventing outbreaks and protecting animal health.

Increasing investments in animal healthcare and livestock disease prevention programs are major factors driving the market. Governments in many countries are implementing large-scale vaccination campaigns to safeguard livestock populations and maintain agricultural productivity. In addition, advancements in veterinary vaccine technologies are improving the effectiveness and safety of foot-and-mouth disease vaccines.

Looking ahead, the Global Food and Mouth Disease Vaccine Market is expected to expand as global demand for animal health products continues to rise. Research institutions and pharmaceutical companies are focusing on developing advanced vaccines that offer longer immunity and broader protection. With the growing emphasis on livestock health management and food security, the market for foot-and-mouth disease vaccines is projected to experience steady growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Animal

  • Cattle
  • Sheep and Goat
  • Swine
  • Others

By Vaccine

  • Modified/Attenuated Live
  • Inactivated (Killed)
  • Other Vaccines

By Distribution Channel

  • Veterinary Hospitals & Clinics
  • Government Institutions
  • Others

COMPANIES PROFILED

  • Merck Co Inc, Biogenesis Bago, Zoetis Inc, Boehringer Ingelheim International GmbH, Indian Immunologicals Limited, Bayer AG, Hester Biosciences Limited, Inner Mongolia Biwei Antai Biotechnology Co Ltd, Brilliant Bio Pharma Limited, Biovet Private Ltd
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL FOOD AND MOUTH DISEASE VACCINE MARKET: BY ANIMAL 2022-2034 (USD MN and Million Doses)

  • 4.1. Market Analysis, Insights and Forecast Animal
  • 4.2. Cattle Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.3. Sheep and Goat Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.4. Swine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 5. GLOBAL FOOD AND MOUTH DISEASE VACCINE MARKET: BY VACCINE 2022-2034 (USD MN and Million Doses)

  • 5.1. Market Analysis, Insights and Forecast Vaccine
  • 5.2. Modified/Attenuated Live Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.3. Inactivated (Killed) Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.4. Other Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 6. GLOBAL FOOD AND MOUTH DISEASE VACCINE MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN and Million Doses)

  • 6.1. Market Analysis, Insights and Forecast Distribution Channel
  • 6.2. Veterinary Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.3. Government Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 7. GLOBAL FOOD AND MOUTH DISEASE VACCINE MARKET: BY REGION 2022-2034(USD MN and Million Doses)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.2.1 By Animal
    • 7.2.2 By Vaccine
    • 7.2.3 By Distribution Channel
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.3.1 By Animal
    • 7.3.2 By Vaccine
    • 7.3.3 By Distribution Channel
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.4.1 By Animal
    • 7.4.2 By Vaccine
    • 7.4.3 By Distribution Channel
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.5.1 By Animal
    • 7.5.2 By Vaccine
    • 7.5.3 By Distribution Channel
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.6.1 By Animal
    • 7.6.2 By Vaccine
    • 7.6.3 By Distribution Channel
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL FOOD AND MOUTH DISEASE VACCINE INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Merck & Co. Inc
    • 9.2.2 Biogenesis Bago
    • 9.2.3 Zoetis Inc
    • 9.2.4 Boehringer Ingelheim International GmbH
    • 9.2.5 Indian Immunologicals Limited
    • 9.2.6 Bayer AG
    • 9.2.7 Hester Biosciences Limited
    • 9.2.8 Inner Mongolia Biwei Antai Biotechnology Co. Ltd
    • 9.2.9 Brilliant Bio Pharma Limited
    • 9.2.10 Biovet Private Ltd